Edition No. 52 · Thu 13 Aug 2026 · Story 16 of 33
"Not worth the risk"
Semafor
Eli Lilly filed six lawsuits against sellers of illicit retatrutide, its unapproved obesity drug.
Edition No. 52 · Thu 13 Aug 2026 · Story 16 of 33
Semafor
Eli Lilly filed six lawsuits against sellers of illicit retatrutide, its unapproved obesity drug.
Newsletters × what it touches on this site × movement. It ranks, it does not reorder the digest.
Each factor is 1.00 when it has nothing to say, so a missing input never sinks a story. The full working is on the method page.
Each morning the Daily Newsletter Digest reads about fifty newsletters, groups them by theme and records an audio episode. These are the day’s most substantive stories from it, each with a direct link to the original article.
Links open the publisher’s own site, which may ask you to subscribe. The one-line summaries are ours; the reporting is theirs. A place tag links to that metro or country on this site, where the same story appears under In the news.